After passionately describing 'real stress,' the Fox News host playfully tried the oral device to relax.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
2 hours ago
- CBS News
Surf therapy offers tranquil setting for those dealing with mental health issues. Here's how it works.
Some people are hitting the water to deal with mental health issues. In the latest installment in our "Breaking the Stigma" series, CBS News New York's Cindy Hsu went to the beach in the Rockaways to learn more about surf therapy. Gina Jurlando is the founder of "Ride the Tide," which offers a unique setting for surf therapy. "I have been a surfer my whole life. I've been in and out of traditional therapy my whole life," Jurlando said, "and sometimes I felt like I just didn't want to talk. I just wanted to do something that was calming, or, you know, talk about things in the lens of surfing." Jurlando says surf therapy can help people who struggle with anxiety and depression, PTSD, women who've experienced sexual trauma, and even children who've experienced loss. Sessions include a land component that encompasses art, discussions and a yoga-like warmup before hitting the waves. "Even getting to the beach sometimes can be a challenge for people dealing with certain mental health issues," surf therapy facilitator Ashley Fallon said. "We talk about challenging yourself when you're in this program, as you're comfortable, and that's what these programs can be as a way to kind of move past any blocks that you might be having." For Sharon Lew, Mick Arieta, and Narisara Vanichanan, one recent session was a day of warm sand, soft rolling waves, restorative movement and supportive affirmations. "I really had this, like, mental, like, clarity that I hadn't had in a very long time," Lew said. "I struggle with depression. I don't always get a chance to get out the door, right? I feel like it's in a safe space in a community that's not judgmental," Arieta said. "It just kind of helps wash away, you know, some of the all these other emotions," Vanichanan added. Therapists say surf therapy should not be a first line treatment for mental health issues, but add research supports that being in and around water does provide positive changes in social connectedness and depressive symptoms. "At the end of the session, I feel like just more calm. It's just like a switch that turns on," Arieta said. "It sounds corny, but feel one with it. There is just a sense of peace that happens," Lew said. "It stays with you, for me, the rest of the day, you know? Into my relationships, into my work. I think it's part of healthy self care, which, you know, doesn't get talked about enough," Vanichanan added. There are mental health practitioners, surf therapy facilitators and safety volunteers at all sessions. Ride the Tide has locations in Rockaway and Asbury Park, New Jersey, and a sliding scale of fees ranging from pay-what-you-can to $75 for a private, two-hour session.
Yahoo
3 hours ago
- Yahoo
Expedition, a startup searching for drugs from China, cuts its first deal
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. A stealthy biotechnology startup has agreed to pay potentially hundreds of millions of dollars for an experimental medicine from Fosun Pharma, adding to a flurry of dealmaking involving drugs discovered in Chinese laboratories. The startup, Expedition Therapeutics, will pay Fosun up to $120 million in upfront cash and development milestones for rights outside of mainland China, Hong Kong and Macau, to a drug codenamed XH-S004. Expedition could hand Fosun up to $525 million more if the drug is approved and hits certain sales targets, the companies said Monday. The deal is the first public announcement so far involving Expedition, a secretive startup incorporated in Delaware last year and backed by Venrock, BVF and Lake Bleu Capital, according to its LinkedIn page. The company is run by Yi Larson, a former Goldman Sachs banker who's held either executive or board positions with Turning Point Therapeutics, LianBio and RayzeBio. Expedition aims to in-license assets from China, a strategy that makes it part of a growing trend in biotech startup creation. The company is one of at least seven companies formed since the start of last year being built around China-originated drugs, according to data collected by BioPharma Dive. Several, such as Candid Therapeutics, Kailera Therapeutics and Ouro Medicines, debuted with funding rounds exceeding $100 million. The proliferation of these new companies has been spurred by fast progress from China's biotech sector. Large pharmaceutical firms have taken notice, inking dozens of deals with China-based companies that, according to the investment bank Jefferies, accounted for about one-fifth of the industry's licensing spending in 2024 and one-third in the first half of this year. On its LinkedIn page, Expedition says it has 'strong visibility into [the] competitive landscape of both U.S. and China biotech ecosystems' as well as an 'extensive knowledge and network of relationships with innovator companies across China.' Its first deal is for a small molecule drug that targets DPP-1, an enzyme linked to the development and progression of multiple inflammatory conditions. DPP-1 is the target of brensocatib, a drug AstraZeneca discovered and licensed to Insmed a decade ago that's since been tested in multiple lung conditions. It succeeded in Phase 3 testing against one of those diseases, bronchiectasis, last year. U.S. regulators cleared it on Tuesday, making brensocatib, now known as Brinsupri, the first drug of its type to get to market. Fosun's drug is currently in Phase 2 testing in China for bronchiectasis and in earlier-stage testing for chronic obstructive pulmonary disease. 'XH-S004 is an exciting compound that targets neutrophilic inflammation, an important underlying driver of a number of chronic respiratory diseases,' Larson said in a statement.'We look forward to partnering with Fosun Pharma in the development of XH-S004 for COPD and other neutrophilic inflammatory diseases to address the significant unmet medical need.' Editor's note: This story has been updated with details about the approval of Brinsupri. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Prevention All Access Membership
I Thought I Was Just a Distracted, Clumsy Person—Until I Got a Diagnosis That Helped Me Turn Things Around I was constantly frazzled: running late, getting overwhelmed, and feeling like a failure. Turns out, there was a reason.10 Healthy Changes It's Never Too Late to Make You haven't missed the boat. Right now is actually the perfect time to turn things Pea and Ricotta Toasts It's the easiest way to eat greens for breakfast. [offer-faq slug="prevention-offer-page-canada"/[/offer-faq] [offer-legal slug="prevention-offer-page-canada"/[/offer-legal] You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
